R. J. Sylvester Et Al. , "Prognostic factors in patients with intermediate and high risk stage TA T1 papillary carcinoma of the bladder treated with maintenance epirubicin or maintenance bacillus Calmette-Guerin. Results of eortc gu group study 30911," EUROPEAN UROLOGY SUPPLEMENTS , vol.7, no.3, pp.178, 2008
Sylvester, R. J. Et Al. 2008. Prognostic factors in patients with intermediate and high risk stage TA T1 papillary carcinoma of the bladder treated with maintenance epirubicin or maintenance bacillus Calmette-Guerin. Results of eortc gu group study 30911. EUROPEAN UROLOGY SUPPLEMENTS , vol.7, no.3 , 178.
Sylvester, R. J., Oosterlinck, W., Brausi, M. A., Kirkels, W. J., Calais Da Silva, F., Gorlia, T., ... Kirkali, Z.(2008). Prognostic factors in patients with intermediate and high risk stage TA T1 papillary carcinoma of the bladder treated with maintenance epirubicin or maintenance bacillus Calmette-Guerin. Results of eortc gu group study 30911. EUROPEAN UROLOGY SUPPLEMENTS , vol.7, no.3, 178.
Sylvester, R. Et Al. "Prognostic factors in patients with intermediate and high risk stage TA T1 papillary carcinoma of the bladder treated with maintenance epirubicin or maintenance bacillus Calmette-Guerin. Results of eortc gu group study 30911," EUROPEAN UROLOGY SUPPLEMENTS , vol.7, no.3, 178, 2008
Sylvester, R. J. Et Al. "Prognostic factors in patients with intermediate and high risk stage TA T1 papillary carcinoma of the bladder treated with maintenance epirubicin or maintenance bacillus Calmette-Guerin. Results of eortc gu group study 30911." EUROPEAN UROLOGY SUPPLEMENTS , vol.7, no.3, pp.178, 2008
Sylvester, R. J. Et Al. (2008) . "Prognostic factors in patients with intermediate and high risk stage TA T1 papillary carcinoma of the bladder treated with maintenance epirubicin or maintenance bacillus Calmette-Guerin. Results of eortc gu group study 30911." EUROPEAN UROLOGY SUPPLEMENTS , vol.7, no.3, p.178.
@article{article, author={R. J. Sylvester Et Al. }, title={Prognostic factors in patients with intermediate and high risk stage TA T1 papillary carcinoma of the bladder treated with maintenance epirubicin or maintenance bacillus Calmette-Guerin. Results of eortc gu group study 30911}, journal={EUROPEAN UROLOGY SUPPLEMENTS}, year=2008, pages={178} }